China’s People’s Daily is reporting the drug Remdesivir is “officially” in clinical trial stage on coronavirus patients in Wuhan’s Jinyintan hospital, APA reports.
“The trial will include 453 critically ill patients and 308 with less severe symptoms, a medical expert said,” the China Daily reported.